5. In the First Schedule to the principal Regulations —(a) | in item 1, in paragraphs (1) and (2), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the dose is administered.”; | (b) | in item 1, after paragraph (2), insert —“(2A) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (c) | in item 2, in paragraphs (1) and (2), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the dose is administered.”; | (d) | in item 2, after paragraph (2), insert —“(2A) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (e) | in item 3, in paragraphs (1) and (2), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the dose is administered.”; | (f) | in item 3, after paragraph (2), insert —“(2A) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (g) | in item 4, in paragraphs (1) and (2), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the dose is administered.”; | (h) | in item 4, after paragraph (2), insert —“(2A) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (i) | in item 4, in paragraph (5), in the second column, replace “At least 2 doses of approved vaccines, one of which is the approved vaccine opposite” with “Vaccination in accordance with paragraph (4)”; | (j) | in item 5, in paragraphs (3), (4), (5) and (6), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the second dose is administered.”; | (k) | in item 5, after paragraph (6), insert —“(6A) | Vaccination in accordance with paragraph (3), (4), (5) or (6), followed by another dose of any approved vaccine, administered at least 86 days after the day the second dose is administered. |
|
| The day the third dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (l) | in item 6, in paragraphs (3), (4), (5), (6), (7) and (8), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the second dose is administered.”; | (m) | in item 6, after paragraph (8), insert —“(8A) | Vaccination in accordance with paragraph (3), (4), (5), (6), (7) or (8), followed by another dose of any approved vaccine, administered at least 86 days after the day the second dose is administered. |
|
| The day the third dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (n) | in item 7, in paragraphs (1) and (2), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the dose is administered.”; | (o) | in item 7, after paragraph (2), insert —“(2A) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; |
|
| (p) | in item 8, in paragraphs (1) and (2), in the fourth column, replace “Indefinite after the start of the period.” with “270th day (including that day) after the day the dose is administered.”; | (q) | in item 8, after paragraph (2), insert —“(2A) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
|
”; and |
|
| (r) | after item 8, insert —“9. | Convidecia (CanSino Biologics COVID‑19 vaccine) |
|
| (1) | One dose of the approved vaccine opposite, administered to a Type T recovered individual at least 28 days after the recovered individual first tested positive for SARS‑CoV‑2. |
|
| 14th day after the dose is administered in accordance with the second column. |
| 270th day (including that day) after the day the dose is administered. |
| | (2) | One dose of the approved vaccine opposite, administered to a Type S recovered individual after his or her recovery from the COVID‑19 infection. |
|
| 14th day after the dose is administered in accordance with the second column. |
| 270th day (including that day) after the day the dose is administered. |
| | (3) | Vaccination in accordance with paragraph (1) or (2), followed by another dose of any approved vaccine, administered at least 86 days after the day the first dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
| | (4) | One dose of the approved vaccine opposite. |
|
| 14th day after the dose is administered. |
| 270th day (including that day) after the day the dose is administered. |
| | (5) | One dose of the approved vaccine opposite, followed by a dose of another approved vaccine, administered at least 86 days after the firstmentioned dose is administered. |
|
| The day the second dose is administered in accordance with the second column. |
| Indefinite after the start of the period. |
| | (6) | Vaccination in accordance with paragraph (5), and where the doses are administered at a shorter interval than as specified in paragraph (5) and allowed by the Director. |
|
| The day the second dose is administered in accordance with the second column. |
| 270th day (including that day) after the day the first dose is administered plus a period fixed by the Director, being not more than 85 days and corresponding to the actual interval between the first and second doses. |
|
”. |
|
|
|